93 related articles for article (PubMed ID: 9291345)
1. Reciprocal changes in circulating interleukin-6 and its soluble receptor during evolving sepsis in leukocytopenic patients.
Ostermann H; Kratz-Albers K; Mesters RM; Kiehl M; Kienast J
J Infect Dis; 1997 Sep; 176(3):825-8. PubMed ID: 9291345
[TBL] [Abstract][Full Text] [Related]
2. Circulating interleukin-6 receptor in patients with sepsis syndrome.
Frieling JT; van Deuren M; Wijdenes J; van der Meer JW; Clement C; van der Linden CJ; Sauerwein RW
J Infect Dis; 1995 Feb; 171(2):469-72. PubMed ID: 7661926
[TBL] [Abstract][Full Text] [Related]
3. Soluble IL-6 receptor leads to a paracrine modulation of the IL-6-induced hepatic acute phase response in double transgenic mice.
Peters M; Odenthal M; Schirmacher P; Blessing M; Fattori E; Ciliberto G; Meyer zum Buschenfelde KH; Rose-John S
J Immunol; 1997 Aug; 159(3):1474-81. PubMed ID: 9233646
[TBL] [Abstract][Full Text] [Related]
4. Soluble interleukin-6 receptors in hematology patients undergoing bone marrow transplantation.
Toren A; Novick D; Or R; Ackerstein A; Slavin S; Nagler A
Transplantation; 1996 Jul; 62(1):138-42. PubMed ID: 8693533
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.
Robak T; Wierzbowska A; Błasińska-Morawiec M; Korycka A; Błoński JZ
Mediators Inflamm; 1999; 8(6):277-86. PubMed ID: 10815616
[TBL] [Abstract][Full Text] [Related]
6. IL-6 and soluble IL-6 receptor levels change differently after surgery both in the blood and in the operative field.
Hisano S; Sakamoto K; Ishiko T; Kamohara H; Ogawa M
Cytokine; 1997 Jun; 9(6):447-52. PubMed ID: 9199879
[TBL] [Abstract][Full Text] [Related]
7. Soluble IL-6 receptors (sIL-6R) in hematological patients receiving immunotherapy with IL-2/IFN-alpha or donor lymphocytes following bone marrow transplantation.
Toren A; Novick D; Ackerstein A; Or R; Slavin S; Nagler A
Bone Marrow Transplant; 1996 Oct; 18(4):721-4. PubMed ID: 8899186
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of soluble IL-6 receptor in multiple myeloma as indicator of disease activity.
Papadaki H; Kyriakou D; Foudoulakis A; Markidou F; Alexandrakis M; Eliopoulos GD
Acta Haematol; 1997; 97(4):191-5. PubMed ID: 9158660
[TBL] [Abstract][Full Text] [Related]
9. [Soluble interleukin-6 receptors in the serum in multiple myeloma].
Scudla V; Kubalová D; Bacovský J; Lukes J; Vavrdová V
Cas Lek Cesk; 1996 Nov; 135(22):719-22. PubMed ID: 8998823
[TBL] [Abstract][Full Text] [Related]
10. Cytokine response to infection in patients with acute myelogenous leukaemia following intensive chemotherapy.
Ostermann H; Rothenburger M; Mesters RM; van de Loo J; Kienast J
Br J Haematol; 1994 Oct; 88(2):332-7. PubMed ID: 7803278
[TBL] [Abstract][Full Text] [Related]
11. Role of different dialysis membranes in the release of interleukin-6-soluble receptor in uremic patients.
Memoli B; Postiglione L; Cianciaruso B; Bisesti V; Cimmaruta C; Marzano L; Minutolo R; Cuomo V; Guida B; Andreucci M; Rossi G
Kidney Int; 2000 Jul; 58(1):417-24. PubMed ID: 10886590
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.
Kotake S; Sato K; Kim KJ; Takahashi N; Udagawa N; Nakamura I; Yamaguchi A; Kishimoto T; Suda T; Kashiwazaki S
J Bone Miner Res; 1996 Jan; 11(1):88-95. PubMed ID: 8770701
[TBL] [Abstract][Full Text] [Related]
13. Concentrations of soluble tumor necrosis factor and interleukin-6 receptors in heatstroke and heatstress.
Hammami MM; Bouchama A; Al-Sedairy S; Shail E; AlOhaly Y; Mohamed GE
Crit Care Med; 1997 Aug; 25(8):1314-9. PubMed ID: 9267943
[TBL] [Abstract][Full Text] [Related]
14. Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsis.
Mesters RM; Flörke N; Ostermann H; Kienast J
Thromb Haemost; 1996 Jun; 75(6):902-7. PubMed ID: 8822584
[TBL] [Abstract][Full Text] [Related]
15. Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease.
Salvi M; Girasole G; Pedrazzoni M; Passeri M; Giuliani N; Minelli R; Braverman LE; Roti E
J Clin Endocrinol Metab; 1996 Aug; 81(8):2976-9. PubMed ID: 8768861
[TBL] [Abstract][Full Text] [Related]
16. Cytokines and soluble cytokine receptors in pleural effusions from septic and nonseptic patients.
Marie C; Losser MR; Fitting C; Kermarrec N; Payen D; Cavaillon JM
Am J Respir Crit Care Med; 1997 Nov; 156(5):1515-22. PubMed ID: 9372669
[TBL] [Abstract][Full Text] [Related]
17. [Level of interleukin-6 (IL-6), soluble interleukin-6 receptors (sIL-6R) and tumor necrosis factor alpha (TNF-alpha) in untreated and progressing multiple myeloma].
Usnarska-Zubkiewicz L
Pol Arch Med Wewn; 1998 Jan; 99(1):30-7. PubMed ID: 9686501
[TBL] [Abstract][Full Text] [Related]
18. Coadministration of interleukin-6 (IL-6) and soluble IL-6 receptor delays progression of wobbler mouse motor neuron disease.
Ikeda K; Kinoshita M; Tagaya N; Shiojima T; Taga T; Yasukawa K; Suzuki H; Okano A
Brain Res; 1996 Jul; 726(1-2):91-7. PubMed ID: 8836549
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis.
Robak T; Gladalska A; Stepień H; Robak E
Mediators Inflamm; 1998; 7(5):347-53. PubMed ID: 9883970
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 and its soluble receptor during acute meningococcal infections: effect of plasma or whole blood exchange.
Frieling JT; van Deuren M; Wijdenes J; van Dalen R; Bartelink AK; van der Linden CJ; Sauerwein RW
Crit Care Med; 1996 Nov; 24(11):1801-5. PubMed ID: 8917028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
